Skip to main content

Podcast

Jonathan Silverberg, MD, PhD, MPH, discusses rise and fall of hydroxychloroquine as the “wonder drug” for COVID-19, and the importance of evidence-based medicine in this podcast.
Patients with cancer who participated in an oncodermatology clinic reported improved quality of life while undergoing treatment, according to a recent study published by researchers at George Washington (GW) Medical School. Adam Friedman, MD, director of the GW Oncodermatology Clinic, discussed this study with The Dermatologist, as well as areas of future research to improve patient care and the impact of COVID-19 on caring for these patients.
Telemedicine use has grown significantly since the beginning of the pandemic. Lawrence Green, MD, interviews Jules Lipoff, MD, chair of the American Academy of Dermatology’s Teledermatology Task Force, about governmental changes to telehealth, the benefits and challenges of telehealth, and the AAD’s toolkit in this podcast.
Carlos Wambier, MD, with Andy Goren, MD, published “What Does Androgenetic Alopecia Have to do with COVID 19?” in the Dermatologic Therapy journal. In this podcast, Dr Wambier discusses the potential role of androgens in SARS-CoV-2 infection risk and severity, as well as his research in health care prophylaxis.
In the second installment, Dr Green and Dr Gelfand discuss the impact of the COVID-19 pandemic and how they are managing patients with psoriasis.
Joel Gelfand, MD, is one of the pioneering researchers who showed a connection between psoriasis and the risk of cardiovascular disease (CVD). In this podcast, Lawrence Green, MD, interviews Dr Gelfand on the latest research in CVD and psoriasis.
Zoe D. Draelos, MD, discusses 3 mechanisms of action for treating acne- decrease nutrients, C acnes lesions and inflammation-and her tips for addressing these, such as facial cleansing products and the use of probiotics.
There are many questions regarding the best way to manage patients with psoriasis during the coronavirus pandemic, particularly patients on systemic therapies. Dr Lawrence Green discusses how to address patients’ concerns, maintaining a safe work environment if you choose to keep your practice open, and current recommendations for patients on biologics, including anti‑TNF inhibitors.
In this podcast, Adam Friedman, MD, professor of dermatology and interim chair of the department of dermatology at George Washington Medical School, discusses off label uses of various therapies in dermatology, tips for counseling patients, and pearls for getting coverage from insurance companies.
In this podcast, Dr Leventhal discusses some of the common dermatologic adverse effects, therapies for treating these patients, and the importance of onco-dermatology in treating patients with cancer.
Back to Top